These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19445564)

  • 21. Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial.
    Dibble SL; Luce J; Cooper BA; Israel J; Cohen M; Nussey B; Rugo H
    Oncol Nurs Forum; 2007 Jul; 34(4):813-20. PubMed ID: 17723973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Herrington JD; Jaskiewicz AD; Song J
    Cancer; 2008 May; 112(9):2080-7. PubMed ID: 18327813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation.
    Kusnierczyk NM; Saunders EF; Dupuis LL
    Bone Marrow Transplant; 2002 Jul; 30(2):119-24. PubMed ID: 12132051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of a new antiemetic, alizapride, in cancerology (author's transl)].
    Cupissol D; Favier F; Favier C; Serrou B
    Sem Hop; 1982 Jun; 58(22):1370-3. PubMed ID: 6287597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Aprepitant successful for controlling nausea and vomiting in a case having difficulty with control treatment in a standard antienemic therapy involving chemotherapy for gallbladder cancer postoperative recurrence].
    Kawashita Y; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T; Mori H; Hanaoka J
    Gan To Kagaku Ryoho; 2011 May; 38(5):861-4. PubMed ID: 21566455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New directions in managing chemotherapy-related emesis.
    Krasnow SH
    Oncology (Williston Park); 1991 Sep; 5(9 Suppl):19-24. PubMed ID: 1836346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fosaprepitant: a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
    Navari RM
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1733-42. PubMed ID: 18983233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives.
    Schwartzberg LS
    J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathophysiology of treatment-related nausea and vomiting in cancer patients: current models.
    Shelke AR; Mustian KM; Morrow GR
    Indian J Physiol Pharmacol; 2004 Jul; 48(3):256-68. PubMed ID: 15648398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evaluation of drug rechallenge: the casopitant Phase III program.
    Hunt CM; Papay JI; Rich DS; Abissi CJ; Russo MW
    Regul Toxicol Pharmacol; 2010 Dec; 58(3):539-43. PubMed ID: 20932869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
    Jordan K; Voigt W; Schmoll HJ
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Guidelines for prophylaxis and treatment of chemotherapy-induced nausea and vomiting].
    Durand JP; Madelaine I; Scotté F
    Bull Cancer; 2009 Oct; 96(10):951-60. PubMed ID: 19734117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk management in ambulatory anti-cancer therapy, focusing on nausea and vomiting].
    Hatake K
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1758-60. PubMed ID: 22083180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: comparison between elderly and non-elderly patient response.
    Massa E; Astara G; Madeddu C; Dessì M; Loi C; Lepori S; Mantovani G
    Crit Rev Oncol Hematol; 2009 Apr; 70(1):83-91. PubMed ID: 18723369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of nausea and vomiting in children: nursing assessment and intervention.
    Hockenberry-Eaton M; Benner A
    Oncol Nurs Forum; 1990; 17(4):575-84. PubMed ID: 2204886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed.
    Erazo Valle A; Wisniewski T; Figueroa Vadillo JI; Burke TA; Martinez Corona R
    Curr Med Res Opin; 2006 Dec; 22(12):2403-10. PubMed ID: 17257454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
    Herrstedt J
    Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The magic plant as an antiemetic. Cannabinoids for treatment of nausea and vomiting].
    Kreutz S
    Pharm Unserer Zeit; 2007; 36(5):389-92. PubMed ID: 17722146
    [No Abstract]   [Full Text] [Related]  

  • 39. Nausea and emesis: evidence for a biobehavioral perspective.
    Morrow GR; Roscoe JA; Hickok JT; Andrews PR; Matteson S
    Support Care Cancer; 2002 Mar; 10(2):96-105. PubMed ID: 11862499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of P6 acupressure in the prophylaxis of chemotherapy-related nausea and vomiting in breast cancer patients.
    Molassiotis A; Helin AM; Dabbour R; Hummerston S
    Complement Ther Med; 2007 Mar; 15(1):3-12. PubMed ID: 17352966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.